Am­gen clos­es $28B Hori­zon ac­qui­si­tion a month af­ter FTC bat­tle end­ed

Am­gen has sealed its high-pro­file $27.8 bil­lion pur­suit of Hori­zon Ther­a­peu­tics, clos­ing the deal af­ter a lengthy 10-month ac­qui­si­tion process in which the Fed­er­al Trade …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER